

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 7.42812653 |
| 2 | regulation of female gonad development (GO:2000194) | 5.33703439 |
| 3 | adenosine metabolic process (GO:0046085) | 4.96431622 |
| 4 | peripheral nervous system neuron development (GO:0048935) | 4.74653281 |
| 5 | desmosome organization (GO:0002934) | 4.64902457 |
| 6 | hemidesmosome assembly (GO:0031581) | 4.61120909 |
| 7 | iron ion import (GO:0097286) | 4.50070240 |
| 8 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 4.42788453 |
| 9 | neuronal action potential (GO:0019228) | 4.29848129 |
| 10 | behavioral response to pain (GO:0048266) | 4.26429840 |
| 11 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 4.24713824 |
| 12 | glomerular visceral epithelial cell development (GO:0072015) | 4.23866482 |
| 13 | regulation of platelet aggregation (GO:0090330) | 4.23528506 |
| 14 | * negative regulation of complement activation (GO:0045916) | 4.16805073 |
| 15 | ethanol oxidation (GO:0006069) | 4.04451974 |
| 16 | positive regulation of p38MAPK cascade (GO:1900745) | 3.98599202 |
| 17 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.98172174 |
| 18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.94730554 |
| 19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.94730554 |
| 20 | modulation by symbiont of host immune response (GO:0052553) | 3.94730554 |
| 21 | positive regulation by symbiont of host defense response (GO:0052509) | 3.94730554 |
| 22 | modulation by symbiont of host defense response (GO:0052031) | 3.94730554 |
| 23 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.94730554 |
| 24 | neutrophil activation involved in immune response (GO:0002283) | 3.93645981 |
| 25 | membrane budding (GO:0006900) | 3.92236479 |
| 26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.84952625 |
| 27 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.84805315 |
| 28 | negative regulation of protein autophosphorylation (GO:0031953) | 3.84192619 |
| 29 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.83387988 |
| 30 | glomerular epithelial cell development (GO:0072310) | 3.78249689 |
| 31 | * negative regulation of humoral immune response (GO:0002921) | 3.71248772 |
| 32 | lung lobe morphogenesis (GO:0060463) | 3.67458169 |
| 33 | response to water (GO:0009415) | 3.65658649 |
| 34 | potassium ion export (GO:0071435) | 3.64532799 |
| 35 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.61831417 |
| 36 | detection of other organism (GO:0098543) | 3.55665385 |
| 37 | response to peptidoglycan (GO:0032494) | 3.52366390 |
| 38 | * negative regulation of protein activation cascade (GO:2000258) | 3.49920038 |
| 39 | response to laminar fluid shear stress (GO:0034616) | 3.48595345 |
| 40 | macrophage activation involved in immune response (GO:0002281) | 3.40580164 |
| 41 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.39140193 |
| 42 | detection of external biotic stimulus (GO:0098581) | 3.37273045 |
| 43 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.35887458 |
| 44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.35887458 |
| 45 | angiotensin maturation (GO:0002003) | 3.35660146 |
| 46 | response to pain (GO:0048265) | 3.34777308 |
| 47 | antibacterial humoral response (GO:0019731) | 3.34453518 |
| 48 | primary alcohol catabolic process (GO:0034310) | 3.33815252 |
| 49 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.33181059 |
| 50 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.31690743 |
| 51 | ethanol metabolic process (GO:0006067) | 3.28896462 |
| 52 | antimicrobial humoral response (GO:0019730) | 3.28885423 |
| 53 | negative regulation of glycoprotein metabolic process (GO:1903019) | 3.25564360 |
| 54 | citrulline biosynthetic process (GO:0019240) | 3.23655024 |
| 55 | embryonic process involved in female pregnancy (GO:0060136) | 3.21879227 |
| 56 | neurofilament cytoskeleton organization (GO:0060052) | 3.19771272 |
| 57 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.19699644 |
| 58 | glomerular basement membrane development (GO:0032836) | 3.19561544 |
| 59 | nuclear pore complex assembly (GO:0051292) | 3.19270344 |
| 60 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.18068138 |
| 61 | detection of bacterium (GO:0016045) | 3.17776083 |
| 62 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.17165106 |
| 63 | interferon-gamma secretion (GO:0072643) | 3.13414386 |
| 64 | cellular extravasation (GO:0045123) | 3.12857800 |
| 65 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.10972950 |
| 66 | negative regulation of B cell mediated immunity (GO:0002713) | 3.10972950 |
| 67 | germinal center formation (GO:0002467) | 3.10380899 |
| 68 | purine nucleotide salvage (GO:0032261) | 3.08901943 |
| 69 | definitive hemopoiesis (GO:0060216) | 3.06947797 |
| 70 | hepatocyte differentiation (GO:0070365) | 3.06542137 |
| 71 | macrophage activation (GO:0042116) | 3.04930049 |
| 72 | immunoglobulin mediated immune response (GO:0016064) | 3.02767051 |
| 73 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 3.00421090 |
| 74 | type B pancreatic cell proliferation (GO:0044342) | 3.00292975 |
| 75 | urea cycle (GO:0000050) | 2.97300955 |
| 76 | detection of temperature stimulus (GO:0016048) | 2.96740455 |
| 77 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.93201684 |
| 78 | negative regulation of cell killing (GO:0031342) | 2.93201684 |
| 79 | response to ATP (GO:0033198) | 2.90545033 |
| 80 | thrombin receptor signaling pathway (GO:0070493) | 2.88381040 |
| 81 | phospholipid scrambling (GO:0017121) | 2.88093928 |
| 82 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.87831193 |
| 83 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.87287255 |
| 84 | neutrophil activation (GO:0042119) | 2.85867310 |
| 85 | midgut development (GO:0007494) | 2.80926470 |
| 86 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.80413647 |
| 87 | detection of biotic stimulus (GO:0009595) | 2.80185169 |
| 88 | regulation of p38MAPK cascade (GO:1900744) | 2.79339849 |
| 89 | positive regulation of respiratory burst (GO:0060267) | 2.79059485 |
| 90 | negative regulation of interleukin-12 production (GO:0032695) | 2.77817919 |
| 91 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.76641831 |
| 92 | response to host (GO:0075136) | 2.76641831 |
| 93 | response to host defenses (GO:0052200) | 2.76641831 |
| 94 | negative regulation of stress fiber assembly (GO:0051497) | 2.76175447 |
| 95 | regulation of gamma-delta T cell activation (GO:0046643) | 2.73991009 |
| 96 | regulation of platelet activation (GO:0010543) | 2.71328883 |
| 97 | regulation of necroptotic process (GO:0060544) | 2.68450764 |
| 98 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.66601918 |
| 99 | response to host immune response (GO:0052572) | 2.66601918 |
| 100 | negative regulation of interleukin-8 production (GO:0032717) | 2.66455678 |
| 101 | citrulline metabolic process (GO:0000052) | 2.65276801 |
| 102 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.64903293 |
| 103 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.64873494 |
| 104 | natural killer cell mediated immunity (GO:0002228) | 2.64873494 |
| 105 | microglial cell activation (GO:0001774) | 2.64712286 |
| 106 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.63851176 |
| 107 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.63851176 |
| 108 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.63426744 |
| 109 | granulocyte activation (GO:0036230) | 2.63387274 |
| 110 | neutrophil mediated immunity (GO:0002446) | 2.62495884 |
| 111 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.61538422 |
| 112 | positive regulation of muscle hypertrophy (GO:0014742) | 2.61538422 |
| 113 | regulation of hypersensitivity (GO:0002883) | 2.60888648 |
| 114 | renal filtration (GO:0097205) | 2.59461686 |
| 115 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.58819464 |
| 116 | T-helper 1 type immune response (GO:0042088) | 2.58115432 |
| 117 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.57534326 |
| 118 | hypotonic response (GO:0006971) | 2.57401807 |
| 119 | water homeostasis (GO:0030104) | 2.57141921 |
| 120 | nuclear pore organization (GO:0006999) | 2.56865395 |
| 121 | negative regulation of platelet activation (GO:0010544) | 2.55736239 |
| 122 | valine metabolic process (GO:0006573) | 2.55481712 |
| 123 | urea metabolic process (GO:0019627) | 2.55413706 |
| 124 | O-glycan processing (GO:0016266) | 2.54531809 |
| 125 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.54513103 |
| 126 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.54319767 |
| 127 | opsonization (GO:0008228) | 2.53971616 |
| 128 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.53812079 |
| 129 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.52955339 |
| 130 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.52028206 |
| 131 | regulation of water loss via skin (GO:0033561) | 2.51534466 |
| 132 | gland morphogenesis (GO:0022612) | 2.50084921 |
| 133 | regulation of coagulation (GO:0050818) | 2.49623378 |
| 134 | multicellular organismal water homeostasis (GO:0050891) | 2.49616934 |
| 135 | regulation of superoxide anion generation (GO:0032928) | 2.49100658 |
| 136 | B cell mediated immunity (GO:0019724) | 2.48279838 |
| 137 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.48140900 |
| 138 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.48140900 |
| 139 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.47326823 |
| 140 | mesodermal cell differentiation (GO:0048333) | 2.46948127 |
| 141 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.46795414 |
| 142 | urinary tract smooth muscle contraction (GO:0014848) | 2.46693716 |
| 143 | establishment of skin barrier (GO:0061436) | 2.43827390 |
| 144 | sensory perception of smell (GO:0007608) | 2.43528888 |
| 145 | negative regulation of sodium ion transport (GO:0010766) | 2.43220046 |
| 146 | surfactant homeostasis (GO:0043129) | 2.42181940 |
| 147 | leukocyte aggregation (GO:0070486) | 2.41667334 |
| 148 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.40718690 |
| 149 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.38891021 |
| 150 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.38611479 |
| 151 | chemical homeostasis within a tissue (GO:0048875) | 2.37965161 |
| 152 | membrane raft organization (GO:0031579) | 2.37324427 |
| 153 | regulation of mast cell degranulation (GO:0043304) | 2.37302702 |
| 154 | response to growth hormone (GO:0060416) | 2.35860884 |
| 155 | myeloid cell activation involved in immune response (GO:0002275) | 2.35821587 |
| 156 | positive regulation of macrophage differentiation (GO:0045651) | 2.34992565 |
| 157 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.34156974 |
| 158 | detection of molecule of bacterial origin (GO:0032490) | 2.33825607 |
| 159 | activation of Rac GTPase activity (GO:0032863) | 2.32962634 |
| 160 | negative regulation of coagulation (GO:0050819) | 2.32232697 |
| 161 | positive regulation of interferon-alpha production (GO:0032727) | 2.31401645 |
| 162 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.31385278 |
| 163 | nitrogen cycle metabolic process (GO:0071941) | 2.30683152 |
| 164 | regulation of muscle hypertrophy (GO:0014743) | 2.29852989 |
| 165 | cell adhesion mediated by integrin (GO:0033627) | 2.29817377 |
| 166 | myoblast migration (GO:0051451) | 2.29258721 |
| 167 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.29254663 |
| 168 | regulation of leukocyte degranulation (GO:0043300) | 2.29254527 |
| 169 | regulation of blood coagulation (GO:0030193) | 2.29053825 |
| 170 | regulation of hemostasis (GO:1900046) | 2.29053825 |
| 171 | growth hormone receptor signaling pathway (GO:0060396) | 2.28641089 |
| 172 | leukocyte mediated cytotoxicity (GO:0001909) | 2.28575850 |
| 173 | mammary gland epithelial cell proliferation (GO:0033598) | 2.26092536 |
| 174 | transcytosis (GO:0045056) | 2.25983419 |
| 175 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.25916814 |
| 176 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.25886668 |
| 177 | fibroblast migration (GO:0010761) | 2.25718979 |
| 178 | hepatocyte apoptotic process (GO:0097284) | 2.22911303 |
| 179 | positive regulation of coagulation (GO:0050820) | 2.22708632 |
| 180 | atrioventricular valve morphogenesis (GO:0003181) | 2.22462523 |
| 181 | establishment of endothelial barrier (GO:0061028) | 2.22235385 |
| 182 | defense response to Gram-negative bacterium (GO:0050829) | 2.21812300 |
| 183 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.21719769 |
| 184 | negative regulation of granulocyte differentiation (GO:0030853) | 2.20643733 |
| 185 | B cell receptor signaling pathway (GO:0050853) | 2.19844072 |
| 186 | ovulation from ovarian follicle (GO:0001542) | 2.19275938 |
| 187 | organ induction (GO:0001759) | 2.19177106 |
| 188 | sensory perception of chemical stimulus (GO:0007606) | 2.18442995 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.43031134 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.98939386 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.62432539 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.16631696 |
| 5 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.13651626 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.07805911 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.94351484 |
| 8 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.69645405 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.57590943 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.44750280 |
| 11 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.42810050 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.39340307 |
| 13 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.34512143 |
| 14 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.21890125 |
| 15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.21050651 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.19926916 |
| 17 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.19241214 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.05296794 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.04593515 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.98831717 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.97504478 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.89894956 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.87648070 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.85821996 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.85245177 |
| 26 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.82887623 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.81625736 |
| 28 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.81323593 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.77256129 |
| 30 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.76494164 |
| 31 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.71699612 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.71051135 |
| 33 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.68454829 |
| 34 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.68388438 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.67678471 |
| 36 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.67252787 |
| 37 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.65857684 |
| 38 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.64151612 |
| 39 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.64151612 |
| 40 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.63727996 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.58552231 |
| 42 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58336505 |
| 43 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.53133549 |
| 44 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.52585726 |
| 45 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48856348 |
| 46 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.48321739 |
| 47 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.48258116 |
| 48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.47873870 |
| 49 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.45154062 |
| 50 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.42683163 |
| 51 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40290103 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40188648 |
| 53 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.38390879 |
| 54 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.35712306 |
| 55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35659203 |
| 56 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.33912438 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33652304 |
| 58 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33604404 |
| 59 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.33264359 |
| 60 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.31452401 |
| 61 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30974752 |
| 62 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.30349780 |
| 63 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.30184186 |
| 64 | GATA2_19941826_ChIP-Seq_K562_Human | 1.28781556 |
| 65 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.26626567 |
| 66 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.23848628 |
| 67 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.22021844 |
| 68 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21923426 |
| 69 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.21104326 |
| 70 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20983487 |
| 71 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.20440440 |
| 72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19898808 |
| 73 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19189166 |
| 74 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.19176085 |
| 75 | UTX_26944678_Chip-Seq_JUKART_Human | 1.18852419 |
| 76 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.16922746 |
| 77 | MYC_22102868_ChIP-Seq_BL_Human | 1.16359365 |
| 78 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15445603 |
| 79 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15055976 |
| 80 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.14587416 |
| 81 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14386356 |
| 82 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.14065370 |
| 83 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.13459903 |
| 84 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12987677 |
| 85 | * MYB_26560356_Chip-Seq_TH2_Human | 1.12750168 |
| 86 | RXR_22108803_ChIP-Seq_LS180_Human | 1.12487434 |
| 87 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.12466773 |
| 88 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.11392181 |
| 89 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.10468831 |
| 90 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09347528 |
| 91 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08767117 |
| 92 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.08266645 |
| 93 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07877947 |
| 94 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.07337861 |
| 95 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.07184356 |
| 96 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.06657593 |
| 97 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05548939 |
| 98 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.05345849 |
| 99 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04312008 |
| 100 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03275280 |
| 101 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03045546 |
| 102 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02883093 |
| 103 | MAF_26560356_Chip-Seq_TH1_Human | 1.00824656 |
| 104 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99204219 |
| 105 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.99140670 |
| 106 | GATA3_26560356_Chip-Seq_TH2_Human | 0.98448273 |
| 107 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98315444 |
| 108 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.96773408 |
| 109 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96267130 |
| 110 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.95717427 |
| 111 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95662173 |
| 112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95413937 |
| 113 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.95193611 |
| 114 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.95177165 |
| 115 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.94964676 |
| 116 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.94039840 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93764469 |
| 118 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.93280392 |
| 119 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92635945 |
| 120 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.92510037 |
| 121 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.92431129 |
| 122 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91771149 |
| 123 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91769338 |
| 124 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90602359 |
| 125 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90365401 |
| 126 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.89037746 |
| 127 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.88009132 |
| 128 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.87449819 |
| 129 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87444972 |
| 130 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.86586359 |
| 131 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83857855 |
| 132 | MYB_26560356_Chip-Seq_TH1_Human | 0.83536233 |
| 133 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82945792 |
| 134 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82906471 |
| 135 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.81841574 |
| 136 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81776684 |
| 137 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81776684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002736_abnormal_nociception_after | 4.91410136 |
| 2 | MP0001968_abnormal_touch/_nociception | 4.58005557 |
| 3 | MP0002735_abnormal_chemical_nociception | 4.29418124 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.23563230 |
| 5 | MP0001986_abnormal_taste_sensitivity | 3.17443890 |
| 6 | MP0005275_abnormal_skin_tensile | 3.12238607 |
| 7 | MP0002254_reproductive_system_inflammat | 3.10819008 |
| 8 | MP0003436_decreased_susceptibility_to | 2.61944523 |
| 9 | MP0003656_abnormal_erythrocyte_physiolo | 2.57092570 |
| 10 | MP0003303_peritoneal_inflammation | 2.33668076 |
| 11 | MP0006054_spinal_hemorrhage | 2.32795458 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.32433356 |
| 13 | MP0001958_emphysema | 2.24528913 |
| 14 | MP0008004_abnormal_stomach_pH | 2.22873052 |
| 15 | MP0003279_aneurysm | 2.09301469 |
| 16 | MP0002733_abnormal_thermal_nociception | 2.04739607 |
| 17 | MP0010352_gastrointestinal_tract_polyps | 2.00813241 |
| 18 | MP0008057_abnormal_DNA_replication | 2.00554394 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 1.97966483 |
| 20 | MP0004782_abnormal_surfactant_physiolog | 1.96448709 |
| 21 | * MP0002419_abnormal_innate_immunity | 1.95803554 |
| 22 | MP0003566_abnormal_cell_adhesion | 1.94337663 |
| 23 | MP0010771_integument_phenotype | 1.78672794 |
| 24 | * MP0005000_abnormal_immune_tolerance | 1.71143104 |
| 25 | MP0003300_gastrointestinal_ulcer | 1.69965774 |
| 26 | MP0002060_abnormal_skin_morphology | 1.68651977 |
| 27 | MP0008875_abnormal_xenobiotic_pharmacok | 1.67545072 |
| 28 | MP0009785_altered_susceptibility_to | 1.64401316 |
| 29 | MP0005387_immune_system_phenotype | 1.63914448 |
| 30 | MP0001790_abnormal_immune_system | 1.63914448 |
| 31 | MP0002796_impaired_skin_barrier | 1.62828939 |
| 32 | MP0006082_CNS_inflammation | 1.60772478 |
| 33 | MP0001851_eye_inflammation | 1.59071355 |
| 34 | MP0005025_abnormal_response_to | 1.59021030 |
| 35 | MP0005451_abnormal_body_composition | 1.57469639 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.55478055 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.53347443 |
| 38 | MP0005076_abnormal_cell_differentiation | 1.53104527 |
| 39 | MP0003724_increased_susceptibility_to | 1.50972041 |
| 40 | MP0002006_tumorigenesis | 1.49981958 |
| 41 | * MP0001800_abnormal_humoral_immune | 1.48576424 |
| 42 | MP0005023_abnormal_wound_healing | 1.46671745 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.46154598 |
| 44 | MP0009384_cardiac_valve_regurgitation | 1.44365210 |
| 45 | MP0004264_abnormal_extraembryonic_tissu | 1.44009559 |
| 46 | MP0005503_abnormal_tendon_morphology | 1.38017129 |
| 47 | MP0002998_abnormal_bone_remodeling | 1.37574475 |
| 48 | MP0005360_urolithiasis | 1.36034709 |
| 49 | MP0003453_abnormal_keratinocyte_physiol | 1.34219547 |
| 50 | MP0001970_abnormal_pain_threshold | 1.33930169 |
| 51 | MP0004883_abnormal_blood_vessel | 1.33114224 |
| 52 | MP0001853_heart_inflammation | 1.32195574 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.32055798 |
| 54 | MP0002877_abnormal_melanocyte_morpholog | 1.31179858 |
| 55 | MP0000427_abnormal_hair_cycle | 1.31178616 |
| 56 | MP0003950_abnormal_plasma_membrane | 1.30889759 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 1.30364539 |
| 58 | MP0010678_abnormal_skin_adnexa | 1.28776313 |
| 59 | MP0002734_abnormal_mechanical_nocicepti | 1.25929647 |
| 60 | MP0001879_abnormal_lymphatic_vessel | 1.22829084 |
| 61 | MP0003075_altered_response_to | 1.22487558 |
| 62 | MP0000538_abnormal_urinary_bladder | 1.21462939 |
| 63 | MP0001835_abnormal_antigen_presentation | 1.20897515 |
| 64 | MP0009333_abnormal_splenocyte_physiolog | 1.19073069 |
| 65 | MP0000767_abnormal_smooth_muscle | 1.18389391 |
| 66 | MP0004947_skin_inflammation | 1.18299118 |
| 67 | MP0004858_abnormal_nervous_system | 1.17526220 |
| 68 | MP0000013_abnormal_adipose_tissue | 1.15639554 |
| 69 | MP0000685_abnormal_immune_system | 1.15077051 |
| 70 | MP0003763_abnormal_thymus_physiology | 1.15052815 |
| 71 | MP0000383_abnormal_hair_follicle | 1.13880638 |
| 72 | MP0005058_abnormal_lysosome_morphology | 1.13064529 |
| 73 | MP0003448_altered_tumor_morphology | 1.12128496 |
| 74 | MP0003045_fibrosis | 1.11154111 |
| 75 | MP0000716_abnormal_immune_system | 1.08748670 |
| 76 | MP0008260_abnormal_autophagy | 1.05833609 |
| 77 | MP0006276_abnormal_autonomic_nervous | 1.04909005 |
| 78 | MP0004381_abnormal_hair_follicle | 1.02855368 |
| 79 | MP0003183_abnormal_peptide_metabolism | 1.02648525 |
| 80 | MP0002452_abnormal_antigen_presenting | 1.01616515 |
| 81 | MP0001666_abnormal_nutrient_absorption | 1.01522655 |
| 82 | MP0002168_other_aberrant_phenotype | 1.01469287 |
| 83 | MP0009840_abnormal_foam_cell | 1.01142101 |
| 84 | MP0002166_altered_tumor_susceptibility | 1.00270484 |
| 85 | MP0004233_abnormal_muscle_weight | 0.99531531 |
| 86 | MP0001270_distended_abdomen | 0.99515424 |
| 87 | MP0000858_altered_metastatic_potential | 0.99169768 |
| 88 | MP0008469_abnormal_protein_level | 0.98209236 |
| 89 | MP0003091_abnormal_cell_migration | 0.97480768 |
| 90 | MP0009764_decreased_sensitivity_to | 0.96867007 |
| 91 | MP0005464_abnormal_platelet_physiology | 0.96212865 |
| 92 | MP0002429_abnormal_blood_cell | 0.95632810 |
| 93 | MP0005501_abnormal_skin_physiology | 0.94341270 |
| 94 | MP0002722_abnormal_immune_system | 0.94333415 |
| 95 | MP0001873_stomach_inflammation | 0.93659189 |
| 96 | MP0001216_abnormal_epidermal_layer | 0.93196378 |
| 97 | MP0000579_abnormal_nail_morphology | 0.92889977 |
| 98 | MP0000003_abnormal_adipose_tissue | 0.91700638 |
| 99 | MP0004185_abnormal_adipocyte_glucose | 0.91075271 |
| 100 | MP0009697_abnormal_copulation | 0.90696324 |
| 101 | MP0002132_abnormal_respiratory_system | 0.89577895 |
| 102 | MP0010155_abnormal_intestine_physiology | 0.88474838 |
| 103 | MP0005397_hematopoietic_system_phenotyp | 0.88199175 |
| 104 | MP0001545_abnormal_hematopoietic_system | 0.88199175 |
| 105 | MP0000490_abnormal_crypts_of | 0.87425652 |
| 106 | MP0009278_abnormal_bone_marrow | 0.87403117 |
| 107 | MP0000343_altered_response_to | 0.86516983 |
| 108 | MP0004147_increased_porphyrin_level | 0.85989896 |
| 109 | MP0002405_respiratory_system_inflammati | 0.85710169 |
| 110 | * MP0002136_abnormal_kidney_physiology | 0.85355741 |
| 111 | MP0009931_abnormal_skin_appearance | 0.84227170 |
| 112 | MP0005621_abnormal_cell_physiology | 0.83996433 |
| 113 | MP0000465_gastrointestinal_hemorrhage | 0.82952548 |
| 114 | MP0004019_abnormal_vitamin_homeostasis | 0.82220098 |
| 115 | MP0000703_abnormal_thymus_morphology | 0.82124696 |
| 116 | MP0002332_abnormal_exercise_endurance | 0.80905966 |
| 117 | MP0002009_preneoplasia | 0.80522492 |
| 118 | MP0001542_abnormal_bone_strength | 0.80092476 |
| 119 | MP0003795_abnormal_bone_structure | 0.79645108 |
| 120 | MP0002420_abnormal_adaptive_immunity | 0.77654856 |
| 121 | MP0002396_abnormal_hematopoietic_system | 0.77091121 |
| 122 | MP0001346_abnormal_lacrimal_gland | 0.76841783 |
| 123 | MP0003828_pulmonary_edema | 0.76614642 |
| 124 | * MP0005165_increased_susceptibility_to | 0.76022585 |
| 125 | MP0003866_abnormal_defecation | 0.75673583 |
| 126 | MP0002723_abnormal_immune_serum | 0.75549921 |
| 127 | MP0002933_joint_inflammation | 0.74937919 |
| 128 | MP0005395_other_phenotype | 0.74738549 |
| 129 | MP0000249_abnormal_blood_vessel | 0.74515742 |
| 130 | MP0001845_abnormal_inflammatory_respons | 0.73992828 |
| 131 | MP0005164_abnormal_response_to | 0.73535499 |
| 132 | MP0000689_abnormal_spleen_morphology | 0.73492437 |
| 133 | MP0000749_muscle_degeneration | 0.72645531 |
| 134 | MP0001819_abnormal_immune_cell | 0.72293220 |
| 135 | MP0005083_abnormal_biliary_tract | 0.72198313 |
| 136 | MP0004484_altered_response_of | 0.69862251 |
| 137 | MP0001984_abnormal_olfaction | 0.69516079 |
| 138 | MP0000681_abnormal_thyroid_gland | 0.67440678 |
| 139 | MP0005166_decreased_susceptibility_to | 0.67179895 |
| 140 | MP0002148_abnormal_hypersensitivity_rea | 0.66812003 |
| 141 | MP0002398_abnormal_bone_marrow | 0.66752894 |
| 142 | MP0004272_abnormal_basement_membrane | 0.66569760 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ulnar claw (HP:0001178) | 4.62158800 |
| 2 | Aortic aneurysm (HP:0004942) | 4.49977929 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.47506796 |
| 4 | Subacute progressive viral hepatitis (HP:0006572) | 3.86059872 |
| 5 | Dysautonomia (HP:0002459) | 3.81687891 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.66436542 |
| 7 | Recurrent abscess formation (HP:0002722) | 3.63054407 |
| 8 | Autoimmune thrombocytopenia (HP:0001973) | 3.62050009 |
| 9 | Distal arthrogryposis (HP:0005684) | 3.58698241 |
| 10 | Lip pit (HP:0100267) | 3.55582954 |
| 11 | Distal lower limb muscle weakness (HP:0009053) | 3.53118428 |
| 12 | Vascular tortuosity (HP:0004948) | 3.43130192 |
| 13 | Hyporeflexia of lower limbs (HP:0002600) | 3.37665203 |
| 14 | Abnormality of macrophages (HP:0004311) | 3.37502913 |
| 15 | Agammaglobulinemia (HP:0004432) | 3.37073335 |
| 16 | Myositis (HP:0100614) | 3.35966485 |
| 17 | Orchitis (HP:0100796) | 3.35351942 |
| 18 | Onycholysis (HP:0001806) | 3.27836646 |
| 19 | Arterial tortuosity (HP:0005116) | 3.21374371 |
| 20 | Gastrointestinal stroma tumor (HP:0100723) | 3.19050899 |
| 21 | Mesangial abnormality (HP:0001966) | 3.08129299 |
| 22 | Recurrent bronchitis (HP:0002837) | 3.06807894 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.02160521 |
| 24 | Atrophic scars (HP:0001075) | 3.02021367 |
| 25 | Interstitial pulmonary disease (HP:0006530) | 3.01525288 |
| 26 | Optic neuritis (HP:0100653) | 2.94171556 |
| 27 | Retrobulbar optic neuritis (HP:0100654) | 2.94171556 |
| 28 | Wrist flexion contracture (HP:0001239) | 2.91636407 |
| 29 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.90531449 |
| 30 | Metaphyseal dysplasia (HP:0100255) | 2.84212999 |
| 31 | Milia (HP:0001056) | 2.83913464 |
| 32 | Emphysema (HP:0002097) | 2.82046597 |
| 33 | Pustule (HP:0200039) | 2.76464436 |
| 34 | Right ventricular cardiomyopathy (HP:0011663) | 2.70280066 |
| 35 | Viral hepatitis (HP:0006562) | 2.68588532 |
| 36 | Bronchitis (HP:0012387) | 2.68191225 |
| 37 | Aortic dissection (HP:0002647) | 2.66577620 |
| 38 | Arthropathy (HP:0003040) | 2.65460418 |
| 39 | Facial diplegia (HP:0001349) | 2.65135819 |
| 40 | Spontaneous hematomas (HP:0007420) | 2.61828202 |
| 41 | Broad metatarsal (HP:0001783) | 2.61733590 |
| 42 | Abnormality of the nasal mucosa (HP:0000433) | 2.61318596 |
| 43 | Short nail (HP:0001799) | 2.61297437 |
| 44 | Increased CSF protein (HP:0002922) | 2.60137796 |
| 45 | Cellulitis (HP:0100658) | 2.59532229 |
| 46 | Gingivitis (HP:0000230) | 2.58229158 |
| 47 | Impaired pain sensation (HP:0007328) | 2.56375026 |
| 48 | Abnormality of pain sensation (HP:0010832) | 2.56375026 |
| 49 | Micronodular cirrhosis (HP:0001413) | 2.54847805 |
| 50 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.54098717 |
| 51 | Recurrent sinusitis (HP:0011108) | 2.53965492 |
| 52 | Hypothermia (HP:0002045) | 2.53893489 |
| 53 | Focal segmental glomerulosclerosis (HP:0000097) | 2.51871999 |
| 54 | Papilloma (HP:0012740) | 2.50449167 |
| 55 | Verrucae (HP:0200043) | 2.50449167 |
| 56 | Nasal polyposis (HP:0100582) | 2.49347575 |
| 57 | Spondylolisthesis (HP:0003302) | 2.48126245 |
| 58 | Impaired platelet aggregation (HP:0003540) | 2.47289695 |
| 59 | Abnormal platelet function (HP:0011869) | 2.47289695 |
| 60 | Increased IgE level (HP:0003212) | 2.46576543 |
| 61 | Increased connective tissue (HP:0009025) | 2.45543982 |
| 62 | Keratoconjunctivitis sicca (HP:0001097) | 2.45509506 |
| 63 | Abnormal hemoglobin (HP:0011902) | 2.45075077 |
| 64 | Gastrointestinal infarctions (HP:0005244) | 2.43377541 |
| 65 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.42395527 |
| 66 | Mediastinal lymphadenopathy (HP:0100721) | 2.40127031 |
| 67 | Areflexia of lower limbs (HP:0002522) | 2.40086576 |
| 68 | Fragile skin (HP:0001030) | 2.37742598 |
| 69 | Malnutrition (HP:0004395) | 2.36577400 |
| 70 | Episodic fever (HP:0001954) | 2.34898195 |
| 71 | Distal lower limb amyotrophy (HP:0008944) | 2.34695751 |
| 72 | Thyroid carcinoma (HP:0002890) | 2.33391537 |
| 73 | Xerostomia (HP:0000217) | 2.33039270 |
| 74 | Absent phalangeal crease (HP:0006109) | 2.32467593 |
| 75 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.32456865 |
| 76 | Osteolytic defects of the hand bones (HP:0009699) | 2.32456865 |
| 77 | Urticaria (HP:0001025) | 2.30606248 |
| 78 | Colitis (HP:0002583) | 2.28753424 |
| 79 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.27464627 |
| 80 | Abnormality of glycolipid metabolism (HP:0010969) | 2.27464627 |
| 81 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.27464627 |
| 82 | Stomatitis (HP:0010280) | 2.26734289 |
| 83 | Recurrent skin infections (HP:0001581) | 2.25353489 |
| 84 | Chronic otitis media (HP:0000389) | 2.25130908 |
| 85 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.24380635 |
| 86 | Fatigue (HP:0012378) | 2.24347661 |
| 87 | Ulnar bowing (HP:0003031) | 2.23004952 |
| 88 | Mitral stenosis (HP:0001718) | 2.21587345 |
| 89 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.18036775 |
| 90 | Keratoconjunctivitis (HP:0001096) | 2.16667478 |
| 91 | Myocardial infarction (HP:0001658) | 2.16579327 |
| 92 | Chronic sinusitis (HP:0011109) | 2.15239938 |
| 93 | Vasculitis (HP:0002633) | 2.15053767 |
| 94 | Petechiae (HP:0000967) | 2.15000935 |
| 95 | Obstructive lung disease (HP:0006536) | 2.13757970 |
| 96 | Chronic obstructive pulmonary disease (HP:0006510) | 2.13757970 |
| 97 | Glomerulosclerosis (HP:0000096) | 2.12422889 |
| 98 | Steppage gait (HP:0003376) | 2.11911503 |
| 99 | Osteomyelitis (HP:0002754) | 2.11613216 |
| 100 | Striae distensae (HP:0001065) | 2.10856629 |
| 101 | Recurrent otitis media (HP:0000403) | 2.10453401 |
| 102 | Sparse lateral eyebrow (HP:0005338) | 2.10297897 |
| 103 | Chronic bronchitis (HP:0004469) | 2.10266221 |
| 104 | Loss of speech (HP:0002371) | 2.10124484 |
| 105 | Fragile nails (HP:0001808) | 2.09496395 |
| 106 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.08235832 |
| 107 | Cerebral aneurysm (HP:0004944) | 2.06192444 |
| 108 | Purpura (HP:0000979) | 2.04816525 |
| 109 | Nephritis (HP:0000123) | 2.04230015 |
| 110 | Recurrent fungal infections (HP:0002841) | 2.04061588 |
| 111 | Hypoalbuminemia (HP:0003073) | 2.03748280 |
| 112 | Abnormal albumin level (HP:0012116) | 2.03748280 |
| 113 | Alkalosis (HP:0001948) | 2.03635970 |
| 114 | Autoimmune hemolytic anemia (HP:0001890) | 2.01834798 |
| 115 | Amyloidosis (HP:0011034) | 2.00540176 |
| 116 | Ankyloglossia (HP:0010296) | 2.00052247 |
| 117 | Arterial thrombosis (HP:0004420) | 1.98818189 |
| 118 | Foot dorsiflexor weakness (HP:0009027) | 1.98679599 |
| 119 | Meningitis (HP:0001287) | 1.98480318 |
| 120 | Premature rupture of membranes (HP:0001788) | 1.98183362 |
| 121 | Facial shape deformation (HP:0011334) | 1.98012054 |
| 122 | Potter facies (HP:0002009) | 1.98012054 |
| 123 | Chest pain (HP:0100749) | 1.97856917 |
| 124 | Stridor (HP:0010307) | 1.97197126 |
| 125 | Dilatation of the ascending aorta (HP:0005111) | 1.96414793 |
| 126 | Insidious onset (HP:0003587) | 1.96244969 |
| 127 | Termporal pattern (HP:0011008) | 1.96244969 |
| 128 | Metaphyseal cupping (HP:0003021) | 1.96221889 |
| 129 | Polycythemia (HP:0001901) | 1.95987752 |
| 130 | Submucous cleft hard palate (HP:0000176) | 1.95306281 |
| 131 | Vertebral compression fractures (HP:0002953) | 1.94554087 |
| 132 | Prolonged bleeding time (HP:0003010) | 1.94265635 |
| 133 | Hematochezia (HP:0002573) | 1.94177836 |
| 134 | Abnormality of the fingertips (HP:0001211) | 1.92926829 |
| 135 | Inflammation of the large intestine (HP:0002037) | 1.91764159 |
| 136 | Recurrent viral infections (HP:0004429) | 1.91029130 |
| 137 | Wormian bones (HP:0002645) | 1.90950967 |
| 138 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.89687150 |
| 139 | Gingival bleeding (HP:0000225) | 1.89149333 |
| 140 | Acanthosis nigricans (HP:0000956) | 1.88377402 |
| 141 | Cardiovascular calcification (HP:0011915) | 1.88294861 |
| 142 | Anorexia (HP:0002039) | 1.88040317 |
| 143 | Pulmonary infiltrates (HP:0002113) | 1.87742241 |
| 144 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.86798318 |
| 145 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.86521113 |
| 146 | Hemoptysis (HP:0002105) | 1.85834036 |
| 147 | Absent frontal sinuses (HP:0002688) | 1.85777861 |
| 148 | Menstrual irregularities (HP:0000858) | 1.83860491 |
| 149 | Sepsis (HP:0100806) | 1.83485782 |
| 150 | Bradycardia (HP:0001662) | 1.83444903 |
| 151 | Cone-rod dystrophy (HP:0000548) | 1.83026250 |
| 152 | Protrusio acetabuli (HP:0003179) | 1.82992659 |
| 153 | Plantar hyperkeratosis (HP:0007556) | 1.82787654 |
| 154 | Abnormality of oral frenula (HP:0000190) | 1.82667353 |
| 155 | Periodontitis (HP:0000704) | 1.82433540 |
| 156 | Abnormality of T cell physiology (HP:0011840) | 1.82408672 |
| 157 | Prominent nose (HP:0000448) | 1.81819926 |
| 158 | Ankle contracture (HP:0006466) | 1.81076147 |
| 159 | Aplasia cutis congenita (HP:0001057) | 1.81033636 |
| 160 | Epistaxis (HP:0000421) | 1.80976653 |
| 161 | Lymphopenia (HP:0001888) | 1.80782782 |
| 162 | Bowing of the arm (HP:0006488) | 1.80401757 |
| 163 | Bowed forearm bones (HP:0003956) | 1.80401757 |
| 164 | Gangrene (HP:0100758) | 1.80338157 |
| 165 | Alveolar cell carcinoma (HP:0006519) | 1.79337637 |
| 166 | Dehydration (HP:0001944) | 1.79070390 |
| 167 | Slow saccadic eye movements (HP:0000514) | 1.78229737 |
| 168 | Thick nail (HP:0001805) | 1.77423136 |
| 169 | Peritonitis (HP:0002586) | 1.77142771 |
| 170 | Cheilitis (HP:0100825) | 1.73964760 |
| 171 | Abnormality of the peritoneum (HP:0002585) | 1.73514326 |
| 172 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.72370864 |
| 173 | Entropion (HP:0000621) | 1.70020465 |
| 174 | Gastrointestinal inflammation (HP:0004386) | 1.68959132 |
| 175 | Abnormality of T cell number (HP:0011839) | 1.68578340 |
| 176 | Lower limb hyperreflexia (HP:0002395) | 1.68213838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPKAPK3 | 3.82737928 |
| 2 | MST4 | 3.46220739 |
| 3 | TGFBR2 | 2.74835347 |
| 4 | EPHA3 | 2.71378533 |
| 5 | STK10 | 2.64060534 |
| 6 | MAP4K1 | 2.48274712 |
| 7 | BMPR2 | 2.46997185 |
| 8 | LRRK2 | 2.45318930 |
| 9 | RIPK4 | 2.41305690 |
| 10 | FRK | 2.39604175 |
| 11 | MAP3K2 | 2.13260341 |
| 12 | ERN1 | 2.04985453 |
| 13 | PRPF4B | 1.98502996 |
| 14 | MARK3 | 1.93605009 |
| 15 | SIK3 | 1.90181149 |
| 16 | FER | 1.79215578 |
| 17 | FGFR4 | 1.78353337 |
| 18 | NEK9 | 1.75992668 |
| 19 | IRAK4 | 1.74922605 |
| 20 | EEF2K | 1.72108938 |
| 21 | TRPM7 | 1.70491309 |
| 22 | FGFR3 | 1.70365930 |
| 23 | CSK | 1.65008935 |
| 24 | NEK6 | 1.63387236 |
| 25 | MATK | 1.62083810 |
| 26 | KSR2 | 1.57917022 |
| 27 | MAP3K9 | 1.54777501 |
| 28 | EPHB1 | 1.52395249 |
| 29 | IRAK3 | 1.49876638 |
| 30 | MAP2K1 | 1.43924773 |
| 31 | EIF2AK3 | 1.43155153 |
| 32 | GRK6 | 1.40854917 |
| 33 | MAP3K3 | 1.39155397 |
| 34 | LMTK2 | 1.38454360 |
| 35 | BLK | 1.38210740 |
| 36 | MAP2K2 | 1.36188849 |
| 37 | CDK12 | 1.33559015 |
| 38 | MST1R | 1.32420759 |
| 39 | BRD4 | 1.29790999 |
| 40 | YES1 | 1.28255536 |
| 41 | JAK1 | 1.28224654 |
| 42 | AKT3 | 1.27780229 |
| 43 | MAP3K13 | 1.26292956 |
| 44 | TYK2 | 1.19278715 |
| 45 | RET | 1.16017147 |
| 46 | NTRK1 | 1.15324208 |
| 47 | RPS6KB2 | 1.14699857 |
| 48 | TIE1 | 1.13105796 |
| 49 | NLK | 1.10664479 |
| 50 | GRK1 | 1.10150545 |
| 51 | IRAK1 | 1.09896648 |
| 52 | JAK3 | 1.09738408 |
| 53 | EPHA2 | 1.05636262 |
| 54 | SGK3 | 1.05603315 |
| 55 | TAOK2 | 1.04752525 |
| 56 | HCK | 1.04748108 |
| 57 | PBK | 1.03488680 |
| 58 | PDPK1 | 1.03369123 |
| 59 | MAP2K3 | 1.03129139 |
| 60 | RIPK1 | 1.02339863 |
| 61 | SGK2 | 1.02261970 |
| 62 | MAP3K1 | 1.02119329 |
| 63 | ZAP70 | 1.00614040 |
| 64 | STK24 | 0.97982403 |
| 65 | FGFR2 | 0.97307176 |
| 66 | EIF2AK1 | 0.97051479 |
| 67 | STK39 | 0.95511540 |
| 68 | SCYL2 | 0.93675457 |
| 69 | MAP3K14 | 0.93669217 |
| 70 | LATS2 | 0.93240528 |
| 71 | SIK1 | 0.93083892 |
| 72 | PRKG2 | 0.92772428 |
| 73 | ERBB3 | 0.91541296 |
| 74 | LIMK1 | 0.90172235 |
| 75 | TEC | 0.89207419 |
| 76 | GRK5 | 0.87716842 |
| 77 | OXSR1 | 0.83196890 |
| 78 | HIPK2 | 0.80635622 |
| 79 | PAK4 | 0.79014987 |
| 80 | MAP3K7 | 0.77638604 |
| 81 | MOS | 0.77365274 |
| 82 | RAF1 | 0.77307788 |
| 83 | BRSK2 | 0.76714162 |
| 84 | TTN | 0.74576273 |
| 85 | TAOK3 | 0.74298189 |
| 86 | LATS1 | 0.71508217 |
| 87 | FES | 0.70978062 |
| 88 | IKBKB | 0.70827381 |
| 89 | IRAK2 | 0.69664691 |
| 90 | RPS6KA2 | 0.68125836 |
| 91 | MAP3K6 | 0.67277346 |
| 92 | PDGFRB | 0.67045513 |
| 93 | TXK | 0.66191579 |
| 94 | CDK6 | 0.66055642 |
| 95 | MAP2K6 | 0.66026983 |
| 96 | STK38 | 0.65645773 |
| 97 | MAP3K10 | 0.65138359 |
| 98 | SYK | 0.62444389 |
| 99 | EPHB2 | 0.61907042 |
| 100 | MELK | 0.60883561 |
| 101 | SGK223 | 0.60074719 |
| 102 | SGK494 | 0.60074719 |
| 103 | NME2 | 0.59163137 |
| 104 | ARAF | 0.58160546 |
| 105 | TBK1 | 0.57615934 |
| 106 | KDR | 0.56829607 |
| 107 | MAP3K12 | 0.56442519 |
| 108 | JAK2 | 0.56357676 |
| 109 | MAPKAPK2 | 0.56204835 |
| 110 | WNK1 | 0.55776184 |
| 111 | KSR1 | 0.54826316 |
| 112 | PTK2 | 0.54804727 |
| 113 | WNK4 | 0.54381783 |
| 114 | STK3 | 0.53714319 |
| 115 | PIM2 | 0.53643049 |
| 116 | MAPK12 | 0.53329438 |
| 117 | MARK2 | 0.52200879 |
| 118 | IKBKE | 0.51722027 |
| 119 | TNK2 | 0.51032581 |
| 120 | BTK | 0.50775464 |
| 121 | MAPKAPK5 | 0.49253405 |
| 122 | PHKG2 | 0.49070357 |
| 123 | PHKG1 | 0.49070357 |
| 124 | BMX | 0.49040454 |
| 125 | PTK6 | 0.48805933 |
| 126 | PRKAA2 | 0.47312272 |
| 127 | STK38L | 0.47158639 |
| 128 | TAOK1 | 0.45142629 |
| 129 | LYN | 0.43762720 |
| 130 | PIM1 | 0.43678612 |
| 131 | MAPK11 | 0.43490689 |
| 132 | MYLK | 0.43111403 |
| 133 | MAPK15 | 0.43054575 |
| 134 | LCK | 0.42529293 |
| 135 | MAPK7 | 0.41663158 |
| 136 | CDK8 | 0.40837336 |
| 137 | MAP3K5 | 0.40770782 |
| 138 | TESK1 | 0.40382281 |
| 139 | CDK9 | 0.36718513 |
| 140 | DAPK2 | 0.36671249 |
| 141 | MAP3K8 | 0.36314700 |
| 142 | PDK1 | 0.35445064 |
| 143 | MET | 0.35364152 |
| 144 | ADRBK1 | 0.32693413 |
| 145 | PDK2 | 0.32092305 |
| 146 | PRKCQ | 0.31930262 |
| 147 | MAP3K11 | 0.31478029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.84441458 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.31354475 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.99019936 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.95896825 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.92039120 |
| 6 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.90767422 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 1.90734540 |
| 8 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.86766452 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.79679285 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.79576823 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.77476719 |
| 12 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.75511135 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.71898410 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.71846682 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.70239201 |
| 16 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.66730009 |
| 17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.64166721 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.59976492 |
| 19 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.58835783 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.56160239 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.52147916 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.48870826 |
| 23 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.47645120 |
| 24 | Mineral absorption_Homo sapiens_hsa04978 | 1.42800579 |
| 25 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.42296781 |
| 26 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.41564092 |
| 27 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.41530727 |
| 28 | Thyroid cancer_Homo sapiens_hsa05216 | 1.41043377 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.38998450 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.38312447 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.37923170 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.35260707 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.31116889 |
| 34 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.29448332 |
| 35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.28941755 |
| 36 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.24813396 |
| 37 | Amoebiasis_Homo sapiens_hsa05146 | 1.23512258 |
| 38 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.23084151 |
| 39 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.20361562 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.19515290 |
| 41 | * Viral myocarditis_Homo sapiens_hsa05416 | 1.18900797 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.18339227 |
| 43 | Phagosome_Homo sapiens_hsa04145 | 1.16439726 |
| 44 | Asthma_Homo sapiens_hsa05310 | 1.15684806 |
| 45 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.12611931 |
| 46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.11131059 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.10233192 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.10066673 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 1.05664559 |
| 50 | Adherens junction_Homo sapiens_hsa04520 | 1.05328498 |
| 51 | Leishmaniasis_Homo sapiens_hsa05140 | 1.03784720 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 1.02820376 |
| 53 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.02714733 |
| 54 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.01476957 |
| 55 | Lysosome_Homo sapiens_hsa04142 | 1.01389205 |
| 56 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.98120318 |
| 57 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.97914545 |
| 58 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.96143872 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.95727963 |
| 60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94414192 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94077469 |
| 62 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.94029112 |
| 63 | Bladder cancer_Homo sapiens_hsa05219 | 0.92171682 |
| 64 | Olfactory transduction_Homo sapiens_hsa04740 | 0.91914263 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91633770 |
| 66 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91568896 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.91316702 |
| 68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91314201 |
| 69 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.91134507 |
| 70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.89774663 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.89555998 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.89164286 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.89120350 |
| 74 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.88922675 |
| 75 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.88606959 |
| 76 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.88088362 |
| 77 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.87010390 |
| 78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.86930207 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.86745392 |
| 80 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.85249447 |
| 81 | Hepatitis C_Homo sapiens_hsa05160 | 0.84399969 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.83633330 |
| 83 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.82724374 |
| 84 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.82302008 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.82296469 |
| 86 | Shigellosis_Homo sapiens_hsa05131 | 0.82168600 |
| 87 | Focal adhesion_Homo sapiens_hsa04510 | 0.81901102 |
| 88 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.81747751 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.78467958 |
| 90 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.76991019 |
| 91 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.75249387 |
| 92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.74378798 |
| 93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.73743847 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.73559100 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71953716 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.71823379 |
| 97 | Malaria_Homo sapiens_hsa05144 | 0.71458670 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71228900 |
| 99 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70939279 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70864024 |
| 101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68890590 |
| 102 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.68744183 |
| 103 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67237191 |
| 104 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.66487924 |
| 105 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.65835492 |
| 106 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.65427571 |
| 107 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65156902 |
| 108 | Influenza A_Homo sapiens_hsa05164 | 0.64412021 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.64370947 |
| 110 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.64312313 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.64122744 |
| 112 | ABC transporters_Homo sapiens_hsa02010 | 0.63787671 |
| 113 | Pathways in cancer_Homo sapiens_hsa05200 | 0.62863588 |
| 114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62812989 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61563090 |
| 116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60457946 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60377337 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60224835 |
| 119 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.59739964 |
| 120 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58361120 |
| 121 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.58239473 |
| 122 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58210922 |
| 123 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.58051493 |
| 124 | Retinol metabolism_Homo sapiens_hsa00830 | 0.57493396 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56712352 |
| 126 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.56364786 |
| 127 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56201611 |
| 128 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55869937 |
| 129 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55547839 |
| 130 | Tuberculosis_Homo sapiens_hsa05152 | 0.55406903 |
| 131 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54943031 |
| 132 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.54500726 |
| 133 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54450386 |
| 134 | Endocytosis_Homo sapiens_hsa04144 | 0.53487485 |
| 135 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.53219070 |
| 136 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.52853717 |
| 137 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.52329424 |
| 138 | Pertussis_Homo sapiens_hsa05133 | 0.51709024 |
| 139 | Prostate cancer_Homo sapiens_hsa05215 | 0.51433106 |
| 140 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51143489 |
| 141 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50671262 |
| 142 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.49808632 |
| 143 | Hepatitis B_Homo sapiens_hsa05161 | 0.49740272 |
| 144 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.48116896 |
| 145 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47328997 |

